ContractDevelopment and Commercialisation Agreement • September 29th, 2014 • Dermira, Inc. • Pharmaceutical preparations • New York
[*] Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.
RIGHT OF FIRST NEGOTIATION AGREEMENTRight of First Negotiation Agreement • September 29th, 2014 • Dermira, Inc. • Pharmaceutical preparations • Delaware
This Right of First Negotiation Agreement (this “Agreement”) dated March 28, 2013 is made by and between Dermira, Inc., a Delaware corporation with a principal address at 2055 Woodside Road, Ste. #270, Redwood City, California 94061 (“Dermira”) and Maruho Co. , Ltd., a Japanese corporation with a principal address at 1-5-22 Nakatsu, Kitaku, Osaka, 531-0071, Japan (“Maruho”). Dermira and Maruho may individually be referred to as a “Party” and collectively, as the “Parties.”
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • September 29th, 2014 • Dermira, Inc. • Pharmaceutical preparations • California
This Exclusive License Agreement (“Agreement”) is entered into as of April 26 2013 (“Effective Date”), by and between Rose U LLC, a California limited liability company (“Licensor”), and Dermira, Inc., a Delaware corporation (“Dermira”) (collectively, the “Parties” and individually, a “Party”).
